Arrowhead Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ARWR
CUSIP
04280A100
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 62 4.22 M $67.0 M
2025 Q1 282 103 M $1.32 B
2024 Q4 289 99.7 M $1.87 B
2024 Q3 286 98.1 M $1.90 B
2024 Q2 293 102 M $2.65 B
2024 Q1 296 102 M $2.90 B
2023 Q4 290 82.2 M $2.52 B
2023 Q3 267 74.8 M $2.01 B
2023 Q2 292 72.4 M $2.57 B
2023 Q1 273 73.2 M $1.86 B
2022 Q4 301 79.5 M $3.22 B
2022 Q3 293 71.9 M $2.37 B
2022 Q2 293 72.4 M $2.55 B
2022 Q1 324 69.6 M $3.20 B
2021 Q4 336 68.4 M $4.54 B
2021 Q3 317 66.6 M $4.16 B
2021 Q2 335 67.3 M $5.57 B
2021 Q1 308 69.0 M $4.58 B
2020 Q4 345 70.1 M $5.38 B
2020 Q3 287 68.3 M $2.95 B
2020 Q2 279 69.0 M $2.98 B
2020 Q1 270 66.6 M $1.93 B
2019 Q4 325 66.6 M $4.23 B
2019 Q3 250 65.8 M $1.86 B
2019 Q2 237 68.6 M $1.82 B
2019 Q1 191 59.2 M $1.09 B
2018 Q4 175 59.6 M $740 M
2018 Q3 154 56.5 M $1.08 B
2018 Q2 129 51.9 M $706 M
2018 Q1 101 41.0 M $296 M
2017 Q4 87 23.4 M $86.0 M
2017 Q3 65 15.0 M $64.9 M
2017 Q2 67 15.4 M $25.0 M
2017 Q1 95 24.5 M $45.4 M
2016 Q4 100 25.9 M $40.2 M
2016 Q3 111 30.2 M $222 M
2016 Q2 97 20.6 M $110 M
2016 Q1 8 2.13 M $10.3 M
2015 Q4 1 500 $4.00 k
2015 Q3 1 500 $3.00 k
2015 Q2 1 500 $4.00 k
2015 Q1 1 500 $4.00 k
2014 Q4 1 500 $4.00 k